XML 26 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Current assets:      
Cash and cash equivalents $ 13,764 $ 9,483  
Trade accounts receivable, net 740 421  
Receivable research incentives 1,052 4,774  
Inventories 2,533 2,114  
Prepaid expenses and other current assets 8,190 1,116  
Deferred offering costs 0 1,250  
Total current assets 26,279 19,158  
Property and equipment, net 2,537 3,249  
Operating lease right-of-use assets 8,066 8,578  
Intangible assets, net 262 272  
Other noncurrent assets 1,345 1,353  
Total assets 38,489 32,610  
Current liabilities:      
Trade accounts payable 3,158 2,109  
Accrued expenses and other current liabilities 5,318 3,614  
Current portion of operating lease liabilities 1,461 1,687  
Loans payable, current 2,232 220  
Deferred revenue, current 1,989 2,665  
Promissory note - related party 420 0  
Total current liabilities 14,578 10,295  
Warrant liabilities 5,498 0  
Operating lease liabilities, net of current portion 6,211 6,990  
Loans payable, noncurrent 12,912 12,233  
Deferred revenue, noncurrent 0 54  
Other noncurrent liabilities 0 18  
Total liabilities 39,199 29,590  
Commitments and contingencies (Note 10)  
Stockholders' (deficit) equity:      
Non-redeemable convertible preferred stock, no par value; 137,765,828 shares authorized as of June 30, 2022 and 137,765,828 shares issued and outstanding as of December 31, 2021. [1] 0 189,881  
Common stock [1] 11 0  
Additional paid-in capital 372,840 148,850  
Accumulated deficit (363,136) (325,268)  
Accumulated other comprehensive loss (10,425) (10,443)  
Total stockholders' (deficit) equity (710) 3,020 $ 30,237
Total liabilities and stockholders' equity $ 38,489 32,610  
DWave System [Member]      
Current assets:      
Cash and cash equivalents   9,483 21,335
Trade accounts receivable, net   421 590
Receivable research incentives   4,774 15,585
Inventories   2,114 2,521
Prepaid expenses and other current assets   1,116 1,253
Deferred offering costs   1,250 0
Total current assets   19,158 41,284
Property and equipment, net   3,249 2,894
Operating lease right-of-use assets   8,578 2,948
Intangible assets, net   272 148
Other noncurrent assets   1,353 187
Total assets   32,610 47,461
Current liabilities:      
Trade accounts payable   2,109 2,176
Accrued expenses and other current liabilities   3,614 3,183
Current portion of operating lease liabilities   1,687 1,544
Loans payable, current   220 355
Deferred revenue, current   2,665 4,713
Total current liabilities   10,295 11,971
Operating lease liabilities, net of current portion   6,990 1,440
Loans payable, noncurrent   12,233 1,321
Deferred revenue, noncurrent   54 0
Other noncurrent liabilities   18 0
Total liabilities   29,590 14,732
Commitments and contingencies (Note 10)  
Stockholders' (deficit) equity:      
Non-redeemable convertible preferred stock, no par value; 137,765,828 shares authorized as of June 30, 2022 and 137,765,828 shares issued and outstanding as of December 31, 2021.   189,881 189,881
Common stock   2,610 2,492
Additional paid-in capital   146,240 144,537
Accumulated deficit   (325,268) (293,723)
Accumulated other comprehensive loss   (10,443) (10,458)
Total stockholders' (deficit) equity   3,021 32,729
Total liabilities and stockholders' equity   $ 32,610 $ 47,461
[1] Shares of legacy non-redeemable convertible preferred stock and legacy common stock have been retroactively restated to give effect to the Business Combination.